Market Research

Minimal Residual Disease Testing Global Market Report 2023

Best Price Guarantee Length Publisher Published Date SKU
from $5,000 275 Pages The Business Research Company July, 2023 BRC17992017
Best Price Guarantee
Price from $5,000
Length 275 Pages
Publisher The Business Research Company
Published Date July, 2023
SKU BRC17992017

Minimal Residual Disease Testing Global Market Report 2023


Including: 1) By Test Type: DNA - Based Test; RNA- Based Test; Immunological Test2) By Technology: Flow Cytometry; Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS)3) By Application: Hematological Malignancies; Leukemia; Lymphoma; Solid Tumors4) By End User: Hospitals And Specialty Clinics; Diagnostic Laboratories; Academic and Research InstitutesCovering: Natera Inc.; Guardant Health; Laboratory Corporation of America Holdings; QIAGEN N.V; F. Hoffmann-La Roche Ltd


Minimal Residual Disease Testing Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on minimal residual disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for minimal residual disease testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The minimal residual disease testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Test Type: DNA - Based Test; RNA- Based Test; Immunological Test
2) By Technology: Flow Cytometry; Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Other Technologies

3) By Application: Hematological Malignancies; Leukemia; Lymphoma; Solid Tumors; Other Application

4) By End User: Hospitals And Specialty Clinics; Diagnostic Laboratories; Academic and Research Institutes; Other End Users

Companies Mentioned: Natera Inc.; Guardant Health; Laboratory Corporation of America Holdings; QIAGEN N.V; F. Hoffmann-La Roche Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Minimal Residual Disease Testing Market Characteristics
3. Minimal Residual Disease Testing Market Trends And Strategies
4. Minimal Residual Disease Testing Market - Macro Economic Scenario
4.1. COVID-19 Impact On Minimal Residual Disease Testing Market
4.2. Ukraine-Russia War Impact On Minimal Residual Disease Testing Market
4.3. Impact Of High Inflation On Minimal Residual Disease Testing Market
5. Minimal Residual Disease Testing Market Size And Growth
5.1. Global Minimal Residual Disease Testing Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Minimal Residual Disease Testing Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Minimal Residual Disease Testing Market Segmentation
6.1. Global Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
DNA - Based Test
RNA- Based Test
Immunological Test
6.2. Global Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Other Technologies
6.3. Global Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hematological Malignancies
Leukemia
Lymphoma
Solid Tumors
Other Application
6.4. Global Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals And Specialty Clinics
Diagnostic Laboratories
Academic and Research Institutes
Other End Users
7. Minimal Residual Disease Testing Market Regional And Country Analysis
7.1. Global Minimal Residual Disease Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Minimal Residual Disease Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Minimal Residual Disease Testing Market
8.1. Asia-Pacific Minimal Residual Disease Testing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Minimal Residual Disease Testing Market
9.1. China Minimal Residual Disease Testing Market Overview
9.2. China Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Minimal Residual Disease Testing Market
10.1. India Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Minimal Residual Disease Testing Market
11.1. Japan Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Minimal Residual Disease Testing Market
12.1. Australia Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Minimal Residual Disease Testing Market
13.1. Indonesia Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Minimal Residual Disease Testing Market
14.1. South Korea Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Minimal Residual Disease Testing Market
15.1. Western Europe Minimal Residual Disease Testing Market Overview
15.2. Western Europe Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Minimal Residual Disease Testing Market
16.1. UK Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Minimal Residual Disease Testing Market
17.1. Germany Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Minimal Residual Disease Testing Market
18.1. France Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Minimal Residual Disease Testing Market
19.1. Eastern Europe Minimal Residual Disease Testing Market Overview
19.2. Eastern Europe Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Minimal Residual Disease Testing Market
20.1. Russia Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Minimal Residual Disease Testing Market
21.1. North America Minimal Residual Disease Testing Market Overview
21.2. North America Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Minimal Residual Disease Testing Market
22.1. USA Minimal Residual Disease Testing Market Overview
22.2. USA Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Minimal Residual Disease Testing Market
23.1. South America Minimal Residual Disease Testing Market Overview
23.2. South America Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Minimal Residual Disease Testing Market
24.1. Brazil Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Minimal Residual Disease Testing Market
25.1. Middle East Minimal Residual Disease Testing Market Overview
25.2. Middle East Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Minimal Residual Disease Testing Market
26.1. Africa Minimal Residual Disease Testing Market Overview
26.2. Africa Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Minimal Residual Disease Testing Market Competitive Landscape And Company Profiles
27.1. Minimal Residual Disease Testing Market Competitive Landscape
27.2. Minimal Residual Disease Testing Market Company Profiles
27.2.1. Natera Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Guardant Health
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Laboratory Corporation of America Holdings
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. QIAGEN N.V
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. F. Hoffmann-La Roche Ltd
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Minimal Residual Disease Testing Market
29. Minimal Residual Disease Testing Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright And Disclaimer

$5,000
$7,500
$10,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings